Upgrades
According to Citigroup, the prior rating for YETI Holdings Inc (NYSE:YETI) was changed from Neutral to Buy. In the fourth quarter, YETI Holdings showed an EPS of $0.74, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $80.89 and a 52-week-low of $15.28. At the end of the last trading period, YETI Holdings closed at $71.78.
According to Citigroup, the prior rating for Albemarle Corp (NYSE:ALB) was changed from Neutral to Buy. In the third quarter, Albemarle showed an EPS of $1.09, compared to $1.53 from the year-ago quarter. The current stock performance of Albemarle shows a 52-week-high of $188.35 and a 52-week-low of $48.89. Moreover, at the end of the last trading period, the closing price was at $159.71.
Citigroup upgraded the previous rating for Sociedad Quimica Y Minera De Chile SA (NYSE:SQM) from Neutral to Buy. Sociedad Quimica Y Minera earned $0.01 in the third quarter, compared to $0.23 in the year-ago quarter. The current stock performance of Sociedad Quimica Y Minera shows a 52-week-high of $60.74 and a 52-week-low of $15.20. Moreover, at the end of the last trading period, the closing price was at $54.29.
According to Benchmark, the prior rating for Amtech Systems Inc (NASDAQ:ASYS) was changed from Hold to Buy. Amtech Systems earned $0.05 in the first quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $8.95 and a 52-week-low of $3.55. At the end of the last trading period, Amtech Systems closed at $8.85.
For TransUnion (NYSE:TRU), Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, TransUnion had an EPS of $0.81, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $102.80 and a 52-week-low of $52.50. TransUnion closed at $92.27 at the end of the last trading period.
For Royal Dutch Shell PLC (NYSE:RDS), ScotiaBank upgraded the previous rating of Sector Underperform to Sector Perform. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Royal Dutch Shell closed at $37.32 at the end of the last trading period.
According to Baird, the prior rating for Vocera Communications Inc (NYSE:VCRA) was changed from Neutral to Outperform. In the fourth quarter, Vocera Communications showed an EPS of $0.28, compared to $0.15 from the year-ago quarter. The current stock performance of Vocera Communications shows a 52-week-high of $49.18 and a 52-week-low of $15.89. Moreover, at the end of the last trading period, the closing price was at $42.03.
Mizuho upgraded the previous rating for HubSpot Inc (NYSE:HUBS) from Neutral to Buy. For the fourth quarter, HubSpot had an EPS of $0.40, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $438.00 and a 52-week-low of $90.83. At the end of the last trading period, HubSpot closed at $431.15.
For Copart Inc (NASDAQ:CPRT), Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. Copart earned $0.79 in the first quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $130.96 and a 52-week-low of $55.69. At the end of the last trading period, Copart closed at $115.97.
Jefferies upgraded the previous rating for Prothena Corp PLC (NASDAQ:PRTA) from Hold to Buy. In the fourth quarter, Prothena Corp showed an EPS of $0.77, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $16.25 and a 52-week-low of $7.10. At the end of the last trading period, Prothena Corp closed at $15.70.
Raymond James upgraded the previous rating for HubSpot Inc (NYSE:HUBS) from Outperform to Strong Buy. In the fourth quarter, HubSpot showed an EPS of $0.40, compared to $0.45 from the year-ago quarter. The current stock performance of HubSpot shows a 52-week-high of $438.00 and a 52-week-low of $90.83. Moreover, at the end of the last trading period, the closing price was at $431.15.
See all analyst ratings upgrades.
Downgrades
For CarGurus Inc (NASDAQ:CARG), DA Davidson downgraded the previous rating of Buy to Neutral. In the fourth quarter, CarGurus showed an EPS of $0.32, compared to $0.17 from the year-ago quarter. The current stock performance of CarGurus shows a 52-week-high of $36.54 and a 52-week-low of $14.25. Moreover, at the end of the last trading period, the closing price was at $34.73.
According to JP Morgan, the prior rating for Axon Enterprise Inc (NASDAQ:AXON) was changed from Overweight to Neutral. For the third quarter, Axon Enterprise had an EPS of $0.40, compared to year-ago quarter EPS of $0.28. At the moment, the stock has a 52-week-high of $212.37 and a 52-week-low of $160.30. Axon Enterprise closed at $203.51 at the end of the last trading period.
Truist Securities downgraded the previous rating for Treehouse Foods Inc (NYSE:THS) from Buy to Hold. For the fourth quarter, Treehouse Foods had an EPS of $1.07, compared to year-ago quarter EPS of $1.10. The current stock performance of Treehouse Foods shows a 52-week-high of $53.98 and a 52-week-low of $33.50. Moreover, at the end of the last trading period, the closing price was at $49.40.
According to Truist Securities, the prior rating for Limelight Networks Inc (NASDAQ:LLNW) was changed from Buy to Hold. Limelight Networks earned $0.03 in the fourth quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $8.19 and a 52-week-low of $3.43. At the end of the last trading period, Limelight Networks closed at $4.56.
Citigroup downgraded the previous rating for Children's Place Inc (NASDAQ:PLCE) from Neutral to Sell. In the third quarter, Children's Place showed an EPS of $1.44, compared to $3.03 from the year-ago quarter. The stock has a 52-week-high of $79.03 and a 52-week-low of $9.25. At the end of the last trading period, Children's Place closed at $76.26.
For Treehouse Foods Inc (NYSE:THS), Credit Suisse downgraded the previous rating of Outperform to Neutral. In the fourth quarter, Treehouse Foods showed an EPS of $1.07, compared to $1.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.98 and a 52-week-low of $33.50. Treehouse Foods closed at $49.40 at the end of the last trading period.
For Hyatt Hotels Corp (NYSE:H), Berenberg downgraded the previous rating of Hold to Sell. Hyatt Hotels earned $1.48 in the third quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.98 and a 52-week-low of $24.02. Hyatt Hotels closed at $73.97 at the end of the last trading period.
For Norwegian Cruise Line Holdings Ltd (NYSE:NCLH), Berenberg downgraded the previous rating of Buy to Hold. For the third quarter, Norwegian Cruise Line had an EPS of $2.35, compared to year-ago quarter EPS of $2.23. The current stock performance of Norwegian Cruise Line shows a 52-week-high of $54.28 and a 52-week-low of $7.03. Moreover, at the end of the last trading period, the closing price was at $23.79.
Berenberg downgraded the previous rating for Royal Caribbean Group (NYSE:RCL) from Hold to Sell. For the third quarter, Royal Caribbean Group had an EPS of $5.62, compared to year-ago quarter EPS of $4.27. The current stock performance of Royal Caribbean Group shows a 52-week-high of $118.03 and a 52-week-low of $19.25. Moreover, at the end of the last trading period, the closing price was at $67.89.
Berenberg downgraded the previous rating for Carnival Corp (NYSE:CCL) from Hold to Sell. Carnival earned $2.02 in the fourth quarter, compared to $0.62 in the year-ago quarter. The stock has a 52-week-high of $44.44 and a 52-week-low of $7.80. At the end of the last trading period, Carnival closed at $20.73.
According to Jefferies, the prior rating for Esperion Therapeutics Inc (NASDAQ:ESPR) was changed from Buy to Hold. In the third quarter, Esperion Therapeutics showed an EPS of $3.07, compared to $2.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.98 and a 52-week-low of $23.90. Esperion Therapeutics closed at $30.74 at the end of the last trading period.
For Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), JP Morgan downgraded the previous rating of Overweight to Neutral. Ultragenyx Pharmaceutical earned $0.37 in the fourth quarter, compared to $1.62 in the year-ago quarter. The current stock performance of Ultragenyx Pharmaceutical shows a 52-week-high of $179.65 and a 52-week-low of $31.99. Moreover, at the end of the last trading period, the closing price was at $162.78.
Barclays downgraded the previous rating for Iridium Communications Inc (NASDAQ:IRDM) from Overweight to Underweight. Iridium Communications earned $0.06 in the fourth quarter, compared to $0.82 in the year-ago quarter. The current stock performance of Iridium Communications shows a 52-week-high of $54.65 and a 52-week-low of $16.87. Moreover, at the end of the last trading period, the closing price was at $46.11.
For Williams-Sonoma Inc (NYSE:WSM), Oppenheimer downgraded the previous rating of Outperform to Perform. Williams-Sonoma earned $2.56 in the third quarter, compared to $1.02 in the year-ago quarter. The stock has a 52-week-high of $151.16 and a 52-week-low of $26.01. At the end of the last trading period, Williams-Sonoma closed at $127.65.
Raymond James downgraded the previous rating for Limelight Networks Inc (NASDAQ:LLNW) from Outperform to Market Perform. Limelight Networks earned $0.03 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Limelight Networks shows a 52-week-high of $8.19 and a 52-week-low of $3.43. Moreover, at the end of the last trading period, the closing price was at $4.56.
SVB Leerink downgraded the previous rating for Amicus Therapeutics Inc (NASDAQ:FOLD) from Outperform to Market Perform. Amicus Therapeutics earned $0.22 in the third quarter, compared to $0.24 in the year-ago quarter. The current stock performance of Amicus Therapeutics shows a 52-week-high of $25.39 and a 52-week-low of $6.25. Moreover, at the end of the last trading period, the closing price was at $18.73.
For Amicus Therapeutics Inc (NASDAQ:FOLD), JP Morgan downgraded the previous rating of Overweight to Neutral. For the third quarter, Amicus Therapeutics had an EPS of $0.22, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $25.39 and a 52-week-low of $6.25. At the end of the last trading period, Amicus Therapeutics closed at $18.73.
DA Davidson downgraded the previous rating for NIC Inc (NASDAQ:EGOV) from Buy to Neutral. NIC earned $0.26 in the fourth quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $35.32 and a 52-week-low of $15.49. At the end of the last trading period, NIC closed at $34.56.
See all analyst ratings downgrades.
Initiations
Ladenburg Thalmann initiated coverage on Artelo Biosciences Inc (NASDAQ:ARTL) with a Buy rating. The price target for Artelo Biosciences is set to $7.00. In the first quarter, Artelo Biosciences showed an EPS of $0.14, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.13 and a 52-week-low of $0.45. Artelo Biosciences closed at $1.63 at the end of the last trading period.
With an Overweight rating, Piper Sandler initiated coverage on Orange County Bancorp Inc (OTC:OCBI). The price target seems to have been set at $35.00 for Orange County Bancorp. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $22.00. Orange County Bancorp closed at $28.00 at the end of the last trading period.
Piper Sandler initiated coverage on Hims & Hers Health Inc (NYSE:HIMS) with a Neutral rating. The price target for Hims & Hers Health is set to $20.00. The stock has a 52-week-high of $25.40 and a 52-week-low of $13.00. At the end of the last trading period, Hims & Hers Health closed at $21.36.
Morgan Stanley initiated coverage on Lordstown Motors Corp (NASDAQ:RIDE) with an Underweight rating. The price target for Lordstown Motors is set to $18.00. In the third quarter, Lordstown Motors showed an EPS of $0.00, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.57 and a 52-week-low of $12.80. Lordstown Motors closed at $30.75 at the end of the last trading period.
With an Underweight rating, Morgan Stanley initiated coverage on Romeo Power Inc (NYSE:RMO). The price target seems to have been set at $12.00 for Romeo Power. At the moment, the stock has a 52-week-high of $32.73 and a 52-week-low of $17.06. Romeo Power closed at $17.64 at the end of the last trading period.
Morgan Stanley initiated coverage on QuantumScape Corp (NYSE:QS) with an Overweight rating. The price target for QuantumScape is set to $70.00. The stock has a 52-week-high of $132.73 and a 52-week-low of $28.63. At the end of the last trading period, QuantumScape closed at $44.94.
With an Overweight rating, Morgan Stanley initiated coverage on Fisker Inc (NYSE:FSR). The price target seems to have been set at $27.00 for Fisker. The stock has a 52-week-high of $23.62 and a 52-week-low of $14.32. At the end of the last trading period, Fisker closed at $15.42.
With an Outperform rating, Oppenheimer initiated coverage on Inovio Pharmaceuticals Inc (NASDAQ:INO). The price target seems to have been set at $35.00 for Inovio Pharmaceuticals. For the third quarter, Inovio Pharmaceuticals had an EPS of $0.26, compared to year-ago quarter EPS of $0.25. The current stock performance of Inovio Pharmaceuticals shows a 52-week-high of $33.79 and a 52-week-low of $3.26. Moreover, at the end of the last trading period, the closing price was at $13.00.
With a Buy rating, Jefferies initiated coverage on Global Ship Lease Inc (NYSE:GSL). The price target seems to have been set at $18.00 for Global Ship Lease. In the third quarter, Global Ship Lease showed an EPS of $0.77, compared to $0.43 from the year-ago quarter. The current stock performance of Global Ship Lease shows a 52-week-high of $17.69 and a 52-week-low of $2.61. Moreover, at the end of the last trading period, the closing price was at $12.86.
For LeMaitre Vascular Inc (NASDAQ:LMAT), KeyBanc initiated coverage, by setting the current rating at Sector Weight. For the third quarter, LeMaitre Vascular had an EPS of $0.37, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $50.53 and a 52-week-low of $18.76. At the end of the last trading period, LeMaitre Vascular closed at $47.53.
See all analyst ratings initiations.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.